Keywords Controlled Substances Act (CSA), Drug Enforcement Administration (DEA), controlled substance.
|
|
- Phebe Craig
- 6 years ago
- Views:
Transcription
1 CHAPTER PHARMACIST RESPONSIBILITIES IN THE MANAGEMENT OF CONTROLLED SUBSTANCES (1 CONTACT HOUR) By Brad Gillespie, PharmD who has over 20 years experience spanning the regulatory, pharmaceutical biotech and human nutritional supplement industries. Author Disclosure: Bradley Gillespie and Elite Professional Education do not have any actual or potential conflicts of interest in relation to this lesson. Universal Activity Number (UAN): H01-P Activity Type: Application-based Initial Release Date: July 2, 2013 Expiration Date: July 2, 2015 Target Audience: Pharmacists in a community-based setting. To Obtain Credit: A minimum test score of 70 percent is needed to obtain a credit. Please submit your answers either by mail, fax, or online at pharmacy.elitecme.com. Questions regarding statements of credit and other customer service issues should be directed to This lesson is $4.00. Educational Review Systems is accredited by the Accreditation Council of Pharmacy Education (ACPE) as a provider of continuing pharmaceutical education. This program is approved for 1 hour (0.1 CEU s) of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit. Abstract Objective To increase pharmacist awareness about the requirements necessary to remain compliant with the federal Controlled Substance Act. Summary As practicing pharmacists, it is critical that we remain totally aware and compliant with all of the laws governing our practice. Because dispensing controlled substances is a major part of our work, and because they are susceptible to abuse, it is critical that we are well versed in all applicable laws governing the role of pharmacists in safely administering controlled substances to patients. Conclusion Evolving national trends in the abuse of controlled substances and the development of new regulations to combat this practice have created an ever-changing clinical practice environment as well as laws to govern it. It is critical that all practicing pharmacists understand how controlled substances are scheduled by the Controlled Substance Act and their responsibilities in ensuring that these potentially dangerous medications are managed throughout the prescribing system. Keywords Controlled Substances Act (CSA), Drug Enforcement Administration (DEA), controlled substance. Learning objectives After the pharmacist has concluded this knowledge-based activity, he or she will be qualified and able to: Understand the role of the Drug Enforcement Administration in regulating the use of controlled Appreciate the importance of a controlled system of distribution to best manage transactions involving controlled Develop a general understanding of how to schedule controlled Become familiar with the appropriate DEA forms needed to document the transaction of controlled Describe the requirements of both electronic and paper-based controlled substance record keeping systems. Understand the requirements for inventorying controlled Understand that there are requirements for Internet pharmacies dispensing controlled substances that are unique and apart from those needed to dispense non-controlled Pre-assessment questions Before beginning this activity, test your precourse knowledge by answering the following questions. Please be aware that these questions will also be included as part of the CPE final examination. 1. Jim Walters, PharmD, has completed his residency in community practice and is preparing to open his own pharmacy. Before he can begin to dispense controlled substances in his pharmacy, he will need to complete which of the following tasks? 2. When opening the pharmacy one morning, Jennifer Carlson, RPh, is horrified to find that the window of the front door to the store was broken, and that the lock had been forcibly opened. When she entered the actual pharmacy area, she was further distressed to find that the shelves had been ransacked, and it appeared that a number of units of anabolic steroids, narcotics and benzodiazepines were missing. In addition to calling the local police authorities, Jennifer will also be required to do which of the following: a. File DEA Form 106 within one business day with the DEA. d. Complete full interviews with all employees to rule out their involvement. 3. Davies Community Pharmacy is preparing for its biennial inventory of controlled While Steen Davies, PharmD, has an idea of how this should be conducted, there are a few key things that he should keep in mind when completing this important count of all controlled Some of things that he should think about when planning the specifics of the inventory include which of the following? substances, regardless of bottle size, is c. All documents created summarizing the inventory must be stored for a period of at least five years. inventory of controlled substances must be stored together to facilitate their simple retrieval. Introduction This course is designed to provide an overview of the Controlled Substances Act and allow practicing pharmacists the opportunity to test their knowledge by evaluating relevant case studies and applying information they have learned in this course to answer questions specific to those cases. This course is not designed to cover all situations. A more detailed and exhaustive program would be required to cover all eventualities that may be encountered by a pharmacist navigating the Controlled Substances Act. Further to that, this course covers only federal law. Pharmacists must also be familiar with the requirements laid out by their respective state pharmacy laws. What is the DEA, and what is the purpose of the Controlled Substances Act (CSA)? In 1973, the Drug Enforcement Administration (DEA) was formed. Its role was primarily to enforce all federal drug laws. The Controlled Substances Act (CSA) and associated regulations formed its backbone, implementing federal requirements governing the disposition of both legal and illicit drugs. In the context of pharmacy, the DEA has two major jobs: prevention of the diversion and abuse of controlled substances and at the same time, ensuring that the supply of legal controlled substances remain available to meet legitimate needs for these drugs. To carry out this important mission, DEA works hand-in-hand with state, local and other federal authorities. Key concepts Within the confines of the CSA, it is critical that all transactions involving controlled substances occur within a closed system of distribution. Within this controlled loop, all entities authorized to touch controlled substances manufacturers, distributors, doctors, and pharmacies must hold the proper DEA registration applicable to their practice. Further, all parties must maintain a strict accounting for all transactions, and maintain Elite Page 1
2 their records in such a way that they are kept separate from other documents and are readily retrievable. 1 Scheduling Substances that fit under the CSA are currently divided into five schedules based on whether they have an acceptable medical use and their relative potential for abuse and likelihood of causing dependence. Schedule I: Schedule I drugs either have no currently medically acceptable use or have a high potential for abuse. Schedule 1 substances include: MPPP, heroin, marijuana, LSD and methaqualone. Additionally, some materials can be temporarily included in Schedule I subject to emergency scheduling. 2 Schedule II: Substances categorized as schedule II all have a high potential for abuse. Further to that, the use of these drugs can lead to severe psychological or physical dependence. Schedule II drugs include codeine, morphine, cocaine, amphetamine, methylphenidate and phenylacetone. 3 Schedule III: Substances in this schedule generally are considered to have a potential for abuse less than substances listed in schedules I or II. The abuse of these drugs may lead to moderate or low physical dependence or high psychological dependence. Schedule II drugs include chlorphentermine; secobarbital; products containing not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit with one or more active, nonnarcotic ingredient in recognized therapeutic amounts; and anabolic steroids. 4 Schedule IV: Compared to substances categorized in schedule II and III, substances in schedule IV have a low potential for abuse or dependence. Schedule IV items include preparations containing not more than 1 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit, alprazolam, fenfluramine, pentazocine and sibutramine. 5 Schedule V: Compared to substances categorized into schedules I, II, III and IV, substances in this schedule have a low potential for abuse and consist primarily of preparations containing limited quantities of certain narcotics. In most cases, preparations appearing in schedule V are used for their antitussive, antidiarrheal and analgesic properties. Examples of Schedule V products include preparations containing not more than 200 milligrams of codeine per 100 milliliters or per 100 grams, pyrovalerone and ezogabine. 6 Registration requirements Before any controlled substances can be dispensed by a pharmacy, that pharmacy needs to be registered with the DEA. This is accomplished online 7 A certificate of this registration must be publically displayed at each pharmacy. This registration must be renewed every three years using DEA Form 224a. 8 Page 2 Transfer or disposal of controlled substances If a pharmacy should ever need to transfer or dispose of controlled substances to another properly registered facility, this transaction must be documented. These records must be maintained and kept available for inspection by DEA for a period of two years. For the transfer of schedule II products, a DEA Form 222 must be completed. 9 For Schedule III-V controlled substances, the transfer must be documented, including the drug name, dosage form, strength, quantity and date transferred. Additionally, the document must include the names, addresses, and DEA registration numbers of all parties involved in the transfer. How to manage a significant loss or theft of controlled substances The theft of a controlled substance is a criminal event that must be reported to the police and DEA within one business day. Should there be any question of whether a crime has occurred, pharmacists should err on the side of conservatism and report the event. 1 The theft of a controlled substance is documented using DEA Form 106. This documentation will describe the actual circumstances of the diversion and include all relevant details. 10 Prescription records Should the pharmacy determine there is a conflict between the requirements of federal and state requirements for record keeping, the pharmacy will need to develop a filing system that complies with both federal and state law. Regardless of the filing system chosen, all prescriptions and supporting documents need to be stored in a way that makes them readily retrievable for DEA inspection. If a paper-based system is used, all schedule II prescriptions must be kept separate from all other documents. 1 The requirements governing the use of electronic prescriptions for controlled substances are outlined in 21 C.F.R Briefly, all electronic records must be maintained for two years (although this time requirement does not preempt any longer periods of retention that may be required by other applicable laws or regulations). The electronic system must allow the records to be separated from other prescriptions and must be easily rendered into a readable format. Lastly, prescription records must be sortable by prescriber name, patient, drug and date dispensed. 11 Controlled substances inventory requirements An inventory is a comprehensive and accurate count of all controlled substances on hand. This accounting will be based on an actual count of schedule II controlled substances and a reasonable estimate of schedule III-V controlled substances (except in case of containers holding 1,000 or more dosage units, in which case an actual count is required). The CSA dictates that all inventory records be maintained for at least two years. Schedule II inventory records must be kept separate from all other inventory documents. When are inventories required? At the time of initial DEA registration. Biennially (every two years following initial inventory). For newly scheduled controlled substances, they must be completed as of the effective date of scheduling or change in schedule.1 Ordering controlled substances Only schedule II controlled substances require a specific ordering protocol. DEA Form 222 is required on each occasion that a schedule II controlled substance is distributed, purchased or transferred between properly registered facilities. 9 For schedule III-V controlled substances, pharmacists are required to maintain an invoice or packing slip stating the date that the products were received and confirmation of the order s accuracy. Additionally, these receipts must also document the name of the controlled substance, the formulation, the number of dosage units, and the total number of containers received. These receipts must be maintained using a system that allows them to be readily retrieved for inspection by DEA. 1 Prescription requirements The basic elements for a controlled substance prescription do not vary greatly from those needed for any other prescription based on the CSA, although states may have their own laws governing the prescription of these products. With that said, pharmacists must be cognizant of their responsibility to ensure that every prescription they fill is legitimate within the meaning and intent of the CSA. If a pharmacist has any doubt about the authenticity or validity of a prescription, he or she is under no obligation to fill it. 12 To the contrary, any pharmacist who knowingly fills a questionable prescription for a controlled substance is committing a felony offense. 13 The use of electronic prescriptions for controlled substances is permitted only after their system has obtained a third party audit or certification review, determining that the application meets DEA requirements. Refills are not permitted for schedule II controlled Up to five refills may be obtained for a schedule III-V controlled substances within six months of issuance of the original prescription. 1 Dispensing requirements Labeling requirements for controlled substances are generally the same as for other prescription medications. When actually dispensing, though, controlled substances may be received only by the actual patient or a member of the patient s household. Schedule II controlled substances may be dispensed only pursuant to a written prescription, except in cases of a bona fide emergency, in which case the prescription can be transmitted to the pharmacy telephonically. In this case, the prescriber must provide a written prescription to the pharmacy within seven days. Prescriptions for schedule III-V controlled Elite
3 substances can be delivered by paper, facsimile, orally or electronically, so long as they meet the DEA requirements for such prescriptions. 1 The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 Amended the CSA by including a number of new provisions designed to prevent the illegal distribution and dispensing of controlled substances over the Internet. This act, designed to counteract rogue Internet sites, applies to all controlled Under this act, it is illegal to deliver, distribute or dispense a controlled substance by means of the Internet unless the online pharmacy holds a modified DEA registration authorizing it to operate as an online pharmacy. Operating counter to this act is in violation of 21 U.S.C. 841(h)(1) and subject to potential criminal prosecution. 14 The information contained in this section above is included only as a brief summary. A full description of the requirement of this act is beyond the scope of this course. Pharmacists and pharmacies needing more complete and comprehensive information describing the act should access the actual text of the CSA and DEA regulations. Controlled Substance Act scenarios Scenario 1 Winter Pharmacy is preparing a record keeping system to account for the acquisition, storage and dispensing of controlled To accomplish this within the guidelines set out by the Controlled Substances Act, its owners wisely choose to design a closed system. Critical elements of this inventory control system will include which of the following? a. For sake of simplicity, make sure that all prescriptions (non-controlled and controlled substances) are filed in a single location. b. Maintain a strict accounting of all transactions of controlled c. Ensure that only the pharmacy has the proper DEA registration permits. d. None of the above. Answer: To comply with all provisions of the CSA, any pharmacy that dispenses controlled substances must operate within the confines of a closed system. In essence, this means that every entity that comes into contact with the controlled substance must be properly licensed, registered, and follow proper guidelines. One such guideline stipulates that all involved parties, including Winter Pharmacy, must provide a comprehensive and thorough accounting of all transactions involving controlled Further, all documents on controlled substances must be kept separate and readily retrievable from other records. Scenario 2 Jim Walters, PharmD, has completed his residency in community practice and is preparing to open his own pharmacy. Before he can begin to dispense controlled substances in his pharmacy, he will need to complete which of the following tasks: Answer: Although many procedures must be followed to properly open a pharmacy, if that pharmacy chooses to dispense controlled substances, the CSA requires that additional tasks must also be completed. The first task for Dr. Walters is to properly register his pharmacy with the DEA, After he receives this registration, the certificate indicating his registration needs to be prominently displayed in the pharmacy. In order to procure schedule II controlled substances, Dr. Walters must do so using DEA Form 222. This form is not required for acquiring schedule III-V controlled Scenario 3 After Dr. Walters has been in business for some time, he realizes that due to poor inventory control, he has a number of dosages of oxycodone that have reached their expiry date and are thus not suitable for sale to patients. In response to this finding, Dr. Walters should: a. Mail them back to his wholesaler without documentation. b. Discard the expired pills in an approved refuse receptacle. c. Complete DEA Form 222 and transfer to a properly licensed facility (page 4). d. Contact the manufacturer to request an extension on the expiry date. Answer: The CSA makes it clear that any change in disposition of schedule II controlled substances, including oxycodone, needs to be documented using DEA Form 222. To either return to the wholesaler without documentation or simply discard the doses would be a clear violation of the CSA. It would not be appropriate for Dr. Walters to request an extension on the expiry date. To move these schedule II controlled substances from his inventory, the only legal way to accomplish this, is to send them to another properly licensed facility. This transaction will need to be appropriately documented using DEA Form 222. Scenario 4 When opening the pharmacy one morning, Jennifer Carlson, RPh, is horrified to find that the window of the front door to the store was broken, and that the lock had been forcibly opened. When she entered the actual pharmacy area, she was further distressed to find that the shelves had been ransacked, and it appeared that a number of units of anabolic steroids, narcotics and benzodiazepines were missing. In addition to calling the local police authorities, Jennifer will also be required to which of the following: a. File DEA Form 106 within one business day with the DEA. d. Complete full interviews with all employees to rule out their involvement. Answer: While there may be a number of business-related responses to a theft of controlled substances that Jennifer may elect to accomplish, the CSA is clear that a DEA Form 106 needs to be filed with DEA within one business day. DEA Form 106 describes the circumstances and details of the theft. Although items b, c and d, may be reasonable responses, they are not mandated by the CSA. Scenario 5 Mammoth Lakes Community Pharmacy, in an effort to create greater levels of patient safety and improve efficiencies, is considering replacing its antiquated paper record keeping system with a state-of-theart electronic system. Unfortunately, the pharmacy manager, Jim Edwards, PharmD, finds that the more vendors he speaks to, the more confused he gets about the requirements of such a system. Whichever system Mammoth Lakes ends up using, it is critical that it addresses which of the following key elements? a. The selected system complies only with federal DEA regulations, as these supersede state laws. b. The system should simplify its approach to filing by making sure that all prescriptions for controlled substances remain together. c. To comply with DEA regulations, all schedule II prescriptions need to be maintained in a readily retrievable state for a period of at least two years. d. None of the above elements are needed. Answer: Electronic pharmacy data systems can be complex, creating confusion for the people who need to select an appropriately designed system. Nonetheless, whether a paper, or electronic structure is employed, the CSA is clear that prescriptions for all schedule II controlled substances need to be kept separate from other documents in a readily retrievable state for no less than two years. Further to that, systems need to be designed to be compliant with all laws, both state and federal. Scenario 6 Davies Community Pharmacy is preparing for its biennial inventory of controlled While Steen Davies, PharmD, has an idea of how this should be conducted, there are a few key things that he should keep in mind when completing this important count of all controlled Some of things that he should think about when planning the specifics of the inventory include which of the following? Elite Page 3
4 Page 4 substances, regardless of bottle size, is c. All documents created summarizing the inventory must be stored for a period of at least five years. inventory of controlled substances must be stored together to facilitate their simple retrieval Answer: The inventorying of all controlled substances is critical to maintaining compliance with the CSA. Exact counts are required only for schedule II controlled substances and other controlled substances in bottles containing 1,000 or more dosage units. All documents must be maintained for at least two years, with schedule II records kept separate from the others. Scenario 7 Kim Maxon, PharmD, the pharmacist in charge of Arrow Community Pharmacy, is working with her pharmacy technician to prepare its regular medication order. In addition to non-controlled substances, this order will also call for a number of medications that are categorized as schedule III-V, as well as for some ADHD medications, which fall under schedule II. To complete the submission and receipt of this order, Kim will need to ensure that which of the following tasks is accomplished? a. All of the ADHD medications will need to be ordered using DEA Form 222. b. DEA Form 222 will need to be completed, including all of the controlled c. For the schedule III-V controlled substances, Kim is required to maintain an invoice or packing slip stating the date that the products were ordered from the wholesaler. d. The receipts or invoices that are included with the shipment must be accounted for and signed by Dr. Maxon, as she is the pharmacist in charge Answer: According to ordering provisions laid out in the CSA, all orders for schedule II controlled substances will need to be made using DEA Form 222. The other controlled substances can be ordered using regular order forms. The CSA does not require that receipts or invoices documenting the orders are signed for by the pharmacist in charge, but does require that the receipt date is noted on the invoice and that it is filed in a way that they can be readily retrieved by DEA. Scenario 8 Lawrence Campbell, RPh, is nearing the end of his shift at the Eagle Community Pharmacy when a man approaches the prescription drop-off area. The well-dressed man presents a prescription to Lawrence for a total of milligram oxycodone tablets. While at first glance, the prescription appears legitimate, upon closer examination, Lawrence notes that the patient s name is slightly smeared. To try to validate the prescription, Lawrence asks the man why he was being prescribed the medication. The customer hesitates slightly, and then, without making eye contact, states that it is for back pain. Based on these series of events, the best initial approach to managing this situation is for Mr. Campbell to: a. Dispense the medication. b. Contact the prescribing physician to verify the prescription. c. Detain the customer and call the police. d. Ask the customer whether the prescription is authentic. Answer: Lawrence was wise to question the validity of the prescription. Based on the response to his additional inquiry, the patient gave the impression that there may be a problem with the authenticity of the prescription. Based on this, Lawrence had an obligation to ensure that the prescription was genuine before filling it. The proper next steps are subjective, but there are some basic ideas to keep in mind when considering this situation. Dispensing the prescription under these circumstances would be wrong, and a potential violation of the CSA. Detention of the patient, and calling the police, may be appropriate, but is likely not the best initial approach. The best tactic would be to simply contact the physician who allegedly wrote the prescription and ask him or her to verify that it is bona fide. Scenario 9 Jeanna Andrew, pharmacist in charge of Century City Pharmacy, is putting together a list of special requirements specific to the dispensing of schedule II controlled Some of the key elements that must be discussed in her checklist include which of the following? a. The transfer of schedule II substances must be documented using DEA Form 222. b. Schedule II inventory records must be kept separate from all other pharmacy documents. c. If schedule II substances are dispensed under an emergency situation without a written prescription, a paper prescription from the prescriber must be provided to the dispensing pharmacy within seven days. Answer: The CSA is especially clear on the guidelines for handling schedule II controlled All changes in disposition of schedule II controlled substances must be documented using DEA Form 222. Regular inventorying of schedule II controlled substances is also required, and resultant documents must be kept separate from all other pharmacy records in an easily retrievable state. While telephonic emergency prescriptions for schedule II controlled substances are allowed in some circumstances, it is incumbent on the prescribing physician to provide a supportive written prescription within seven days. Scenario 10 James Gilbert, PharmD is realizing his career goals by establishing a large, Internet-based pharmacy. He believes that by opening this service, he can provide excellent service to his customers at competitive prices because of the efficiencies of scale and reduced overhead costs. In addition to regulations and laws governing all pharmacies, though, he should be especially concerned with the rules included in which of the following acts? a. The Ryan Haight Online Pharmacy Consumer Protection Act of b. The Consumer Protection Act. c. The 1962 Kefauver Harris Amendment. d. The 1952 Durham-Humphrey Amendment. Answer: To remain current and relevant, the CSA was amended in 2008 to more closely govern the dispensing of controlled substances over the Internet. Under the provisions of this act, it is illegal to sell controlled substances over the Internet without proper DEA registration (in addition to the requirements of traditional pharmacies). The acts identified in items b, c and d, while important to pharmacy practice, in general, are not as closely aligned with the dispensing of controlled substances over the Internet as that described in item a. References 1. U.S. Department of Justice (2010). Pharmacist s Manual: An Informational Outline of the Controlled Substances Act. Accessed online 26 May 2013 at: deadiversion.usdoj.gov/pubs/manuals/pharm2/pharm_manual.pdf 2. Code of Federal Regulations (2013) Accessed online 26 May 2013 at 3. Code of Federal Regulations (2013) Accessed online 26 May 2013 at 4. Code of Federal Regulations (2013) Accessed online 26 May 2013 at 5. Code of Federal Regulations (2013) Accessed online 26 May 2013 at 6. Code of Federal Regulations (2013) Accessed online 26 May 2013 at 7. U.S. Department of Justice: Drug Enforcement Administration (2013). DEA Form 224. Accessed online 26 May 2013 at: reg_apps/224/224_instruct.htm 8. U.S. Department of Justice: Drug Enforcement Administration (2013). DEA Form 224a. Accessed online 26 May 2013 at: notices/2009/fr08212.htm 9. U.S. Department of Justice: Drug Enforcement Administration (2013). DEA Form 222. Accessed online 26 May 2013 at: U.S. Department of Justice: Drug Enforcement Administration (2013). DEA Form 106. Accessed online 26 May 2013 at: reports/theft/ 11. U.S. Department of Justice: Drug Enforcement Administration (2013). Part 1311 digital certificates- Subpart C electronic prescriptions. Accessed online 26 May 2013 at: U.S. Department of Justice: Drug Enforcement Administration (2013). Title 21 United States Code (USC) Controlled Substances Act: Section 829. Prescriptions. Accessed online 26 May 2013 at: htm 13. United States v. Kershman, 555 F.2d 198 (United States Court Of Appeals, Eighth Circuit, 1977). Accessed on 26 May 2013 line at: gov/c/f2/555/555.f2d html 14. Department Of Justice, Drug Enforcement Administration. 21 CFR Parts 1300, 1301, 1304, 1306, Implementation of the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 (2008). Accessed on 26 May 2013 line at: gov/fed_regs/rules/2009/fr0406.pdf (Final examination questions on next page) Elite
5 PHARMACIST RESPONSIBILITIES IN THE MANAGEMENT OF CONTROLLED SUBSTANCES Final Examination Questions Choose the best answer for questions 1 through 5 and mark your answers online at pharmacy.elitecme.com. 1. Critical elements of a closed inventory control system will include which of the following? a. For sake of simplicity, make sure that all prescriptions (non-controlled and controlled substances) are filed in a single location. b. Maintain a strict accounting of all transactions of controlled c. Ensure that only the pharmacy has the proper DEA registration permits. d. None of the above. 5. What is one of the inventory requirements of the inventory of controlled substances? substances, regardless of bottle size is c. All documents created summarizing the inventory must be stored for a period of at least five years. inventory of controlled substances must be stored together to facilitate their simple retrieval. 2. Before a new pharmacy can begin dispense controlled substances, which task must the pharmacy complete? 3. If a pharmacy should ever need to transfer or dispose of controlled substances to another properly registered facility, the pharmacy must: a. Mail back the controlled substances without documentation. b. Discard the expired pills in an approved refuse receptacle. c. Complete DEA Form 222 and transfer to a properly licensed facility. d. Contact the manufacturer to request an extension on the expiry date. 4. According to the Controlled Substance Act, what is the procedure when a theft of a controlled substance occurs? a. Report to the police and file DEA Form 106 within one business day with the DEA. d. Complete full interviews with all employees to rule out their involvement. RPUS01PRE13 Elite Page 5
Management of Controlled Substances
Chapter 10: Pharmacist Responsibilities in the Management of Controlled Substances 1 Contact Hour By Brad Gillespie, PharmD who has over 20 years experience spanning the regulatory, pharmaceutical biotech
More informationin Handling Controlled Substances
Chapter 7: The Pharmacy Technician s Responsibility in Handling Controlled Substances 4 Contact Hours By Bradley Gillespie, PharmD who has over 20 years experience spanning the regulatory, pharmaceutical
More informationGuideline for the Rational Use of Controlled Drugs
Guideline for the Rational Use of Controlled Drugs Ministry of Health Male' Republic of Maldives April 2000 Table of Contents Page Introduction.. 2 1. Procurement and Supply of Controlled Drugs 3 1.1 Import
More informationControlled Substances Program. For Academic Units
Brigham Young University Page 1 Provo, Utah Controlled Substances Program For Academic Units Last Revised: November 30, 2009 Brigham Young University Page 2 TABLE OF CONTENTS Section Title Page 1.0 Overview
More informationLUNCH AND LEARN. January 8, CE Activity Information & Accreditation
LUNCH AND LEARN Pharmacy Law: The Ins and Outs of Controlled Substances January 8, 2016 Featured Speaker: Joseph J. Bogdan, Pharm.D., R.Ph., J.D. Pharmacist Attorney Lisle, Illinois 1 CE Activity Information
More informationUNIVERSITY POLICY. Revised: Contact:
UNIVERSITY POLICY Policy Name: Policy for Controlled Substances Section #: 90.2.3 Section Title: Compliance Approval Authority: Responsible Executive: Responsible Office: Formerly Book: President Adopted:
More informationARKANSAS STATE UNIVERSITY GOVERNING PRINCIPLES FOR THE USE OF CONTROLLED SUBSTANCES IN RESEARCH
ARKANSAS STATE UNIVERSITY GOVERNING PRINCIPLES FOR THE USE OF CONTROLLED SUBSTANCES IN RESEARCH 1.0 INTRODUCTION Arkansas State University (ASU) is committed to enhancing the growth of research and other
More informationUse of Controlled Substances in Research.
3341-7-09 Use of Controlled Substances in Research. Applicability Faculty and staff who hold federal Drug Enforcement Administration (DEA) licenses to use controlled substances for research purposes. Responsible
More informationSECTION PRESCRIPTIONS
SECTION.1800 - PRESCRIPTIONS 21 NCAC 46.1801 EXERCISE OF PROFESSIONAL JUDGMENT IN FILLING PRESCRIPTIONS (a) A pharmacist or device and medical equipment dispenser shall have a right to refuse to fill or
More informationPRODUCTS: All products containing ephedrine (EPH) and pseudoephedrine (PSE). (IC )
INDIANA PRODUCTS: All products containing ephedrine (EPH) and pseudoephedrine (PSE). (IC 35-48- 4-14.7) PRODUCT EXEMPTIONS: EPH or PSE products dispensed pursuant to a prescription (IC 35-48-4-14.7); Sale
More informationMark W. Caverly, Chief Liaison and Policy Section
DEA Issues: An Update Harold Rogers National Prescription Drug Monitoring Meeting Meeting September 24 25, 2009 Mark W. Caverly, Chief Liaison and Policy Section Prescription Drug Abuse Prescription Drug
More informationWikiLeaks Document Release
WikiLeaks Document Release February 2, 2009 Congressional Research Service Report RL34635 The Controlled Substances Act: Regulatory Requirements James E. Nichols and Brian T. Yeh, American Law Division
More informationControlled Substances Program Procedures. UC Merced Environmental Health and Safety August 2015
Controlled Substances Program Procedures UC Merced Environmental Health and Safety August 2015 0 I. Introduction II. III. IV. Definitions Registrations Campus Authorization Requirements V. Training VI.
More informationThis Chapter Contains:
This Chapter Contains: State and Federal Laws Relating to Controlled Substances and Other Medications Drugs Used in Animal Shelters Acquiring Controlled Substances Record Keeping of Controlled Substances
More informationPROGRAM FOR THE USE OF CONTROLLED SUBSTANCES OR PRECURSOR/LIST CHEMICALS IN RESEARCH
San Diego State University Environmental Health and Safety PROGRAM FOR THE USE OF CONTROLLED SUBSTANCES OR PRECURSOR/LIST CHEMICALS IN RESEARCH SUMMARY A number of substances or chemicals regulated by
More informationPART 1306 PRESCRIPTIONS. 21 CFR Ch. II ( Edition)
1305.16 1305.16 Special procedure for filling certain order forms. (a) The purchaser of carfentanil etorphine hydrochloride or diprenorphine shall submit copy 1 and 2 of the order form to the supplier
More informationThe Controlled Substances Act: Regulatory Requirements
Order Code RL34635 The Controlled Substances Act: Regulatory Requirements August 22, 2008 James E. Nichols Law Clerk American Law Division Brian T. Yeh Legislative Attorney American Law Division The Controlled
More informationRULES OF THE TENNESSEE BOARD OF PHARMACY CHAPTER DRUG DONATION REPOSITORY PROGRAM TABLE OF CONTENTS
RULES OF THE TENNESSEE BOARD OF PHARMACY CHAPTER 1140-17 DRUG DONATION REPOSITORY PROGRAM TABLE OF CONTENTS 1140-17-.01 Definitions 1140-17-.02 Purpose 1140-17-.03 Eligibility Criteria for Program Participation
More informationControlled Substance Prescribing: A Physician s Guide. Bethanie Gamble, PharmD Department of Pharmacy Greenville Health System
Controlled Substance Prescribing: A Physician s Guide Bethanie Gamble, PharmD Department of Pharmacy Greenville Health System Objectives Review schedules of controlled substances and their propensity for
More informationThe Controlled Substances Act: Regulatory Requirements
The Controlled Substances Act: Regulatory Requirements Brian T. Yeh Legislative Attorney December 13, 2012 CRS Report for Congress Prepared for Members and Committees of Congress Congressional Research
More informationPHARMACY 543 PHARMACY LAWS & ETHICS MIDTERM EXAMINATION October 29, 1998
PHARMACY 543 PHARMACY LAWS & ETHICS MIDTERM EXAMINATION October 29, 1998 Questions 1 20 are multiple choice; please record answers on Side 2 of a Standard Answer Sheet, Form 1158. Follow the instructions
More informationCrowe Healthcare Webinar Series
Crowe Healthcare Webinar Series Healthcare Providers Ongoing Challenges With Controlled Substances Presented by: Scott Gerard, Healthcare Risk Consulting Partner Eric Jolly, Healthcare Risk Vice President
More informationA. The unlawful possession, use, distribution, manufacture, or dispensing of illicit drugs on EVMS property or at an EVMS off-campus activity.
I. BACKGROUND AND PURPOSE In accordance with the federal Drug Free Workplace Act of 1988 and the federal Drug Free Schools and Communities Act of 1989, EVMS must adopt and implement a program designed
More informationDo not open the test booklet prior to being told to do so.
Last Name: Pharmacy 4054 Pharmacy Law Exam II Do not open the test booklet prior to being told to do so. I, the undersigned student, agree to do my best on the exam and that I have only used resources
More informationPrescribing and Dispensing Drugs
STANDARDS & GUIDELINES Prescribing and Dispensing Drugs TABLE OF CONTENTS Standards and guidelines inform practitioners and the public of CDSBC s expectations for registrants. This document primarily contains
More informationMUNICIPAL COUNCIL OF THE CITY OF BAYONNE
O-17-23 05/17/17 MUNICIPAL COUNCIL OF THE CITY OF BAYONNE AN ORDINANCE AMENDING AND SUPPLEMENTING THE GENERAL ORDINANCES OF THE CITY OF BAYONNE, CHAPTER 6, ALCOHOLIC BEVERAGE CONTROL BE IT ORDAINED, by
More informationStudent Number. PHARMACY 543 PHARMACY LAWS & ETHICS MIDTERM EXAMINATION 2 November 10, 1999
PHARMACY 543 PHARMACY LAWS & ETHICS MIDTERM EXAMINATION 2 November 10, 1999 Questions 1-25 are multiple choice; please record answers on Side 2 of a Standard Answer Sheet, Form 1158. Follow the instructions
More informationVirginia. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Virginia Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationPractice Direction Refill History Recording System
1.0 Scope and Objective: 1.1 Expected Outcome Practice Direction Refill History Recording System This document is a practice direction by Council concerning implementation of concept of prescription refill
More informationOCCUPATIONAL AND PROFESSIONAL LICENSING MEDICINE AND SURGERY PRACTITIONERS MANAGEMENT OF PAIN AND OTHER CONDITIONS WITH CONTROLLED SUBSTANCES
TITLE 16 CHAPTER 10 PART 14 OCCUPATIONAL AND PROFESSIONAL LICENSING MEDICINE AND SURGERY PRACTITIONERS MANAGEMENT OF PAIN AND OTHER CONDITIONS WITH CONTROLLED SUBSTANCES 16.10.14.1 ISSUING AGENCY: New
More informationPharmacy Tech Topics. The Federal Controlled Substances Act: A Primer for the Pharmacy Technician
The Federal Controlled Substances Act: A Primer for the Pharmacy Technician Pharmacy Tech Topics VOLUME 16 ISSUE 1 JANUARY 2011 The Federal Controlled Substances Act: A Primer for the Pharmacy Technician
More informationChanges to the Eighth Edition
Pharmacy Practice and the Law, Eighth Edition Includes Navigate 2 Advantage Access By Richard R. Abood, BS Pharm, JD-Professor Emeritus Pharmacy Practice, Thomas J. Long School of Pharmacy and Health Sciences,
More informationSUBJECT: Effective Date: Policy Number: Controlled Substance and Prescription Drugs 11/30/
Division of Research SUBJECT: Effective Date: Controlled Substance and Prescription Drugs 11/30/2018 Supersedes: Page Of 12/04/2015 04/25/2007 1 6 Responsible Authorities: Vice President, Research Institutional
More informationCDL Drivers Controlled Substance and Alcohol Policy
CDL Drivers Controlled Substance and Alcohol Policy Section 1. General. It is the purpose of this policy to encourage an enlightened viewpoint toward alcoholism and other drug dependencies as behavioral/medical
More informationOpioids And DEA Compliance
Opioids And DEA Compliance Don L. Bell, II Senior Vice President & General Counsel National Association of Chain Drug Stores (703) 837-4231 DBell@NACDS.org Agenda The Opioid Abuse Crisis - Distinguishing
More informationHome Model Legislation Public Safety and Elections. Methamphetamine Reduction Act
Search GO LOGIN LOGOUT HOME JOIN ALEC CONTACT ABOUT MEMBERS EVENTS & MEETINGS MODEL LEGISLATION TASK FORCES ALEC INITIATIVES PUBLICATIONS NEWS Model Legislation Home Model Legislation Public Safety and
More informationSafe Medication Disposal A white position paper Pennsylvania Pharmacists Association February 8, 2009
Safe Medication Disposal A white position paper Pennsylvania Pharmacists Association February 8, 2009 Background and Situation Analysis: Consumers are rightly confused about what to do with their unwanted
More informationStatement Of. The National Association of Chain Drug Stores. For. United States Senate Caucus on International Narcotics Control.
Statement Of The National Association of Chain Drug Stores For United States Senate Caucus on International Narcotics Control Hearing on: Improving Management 10:00 a.m. 226 Dirksen Senate Office Building
More informationOFFICIAL POLICY. Policy Statement
OFFICIAL POLICY 9.1.6 Employee Drug and Alcohol Abuse Policy 2/8/16 Policy Statement Employee Drug and Alcohol Abuse Policy #CofC.HR.DA.03 Revised 12/2001 The Drug-Free Schools and Communities Act The
More informationAHLA. X. Federal Enforcement of Fraud and Abuse Involving Opioid Abuse and Diversion
Fraud and Compliance Forum, October 2017. Click here to access audio. AHLA X. Federal Enforcement of Fraud and Abuse Involving Opioid Abuse and Diversion Michelle Bergholz Frazier Senior Vice President,
More informationNew Mexico. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile New Mexico Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationLouisiana. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Louisiana Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationOPIOID. Opioid Legislation FAQs NEED TO KNOW
OPIOID MICHIGAN OSTEOPATHIC ASSOCIATION APRIL 5, 2018 NEED TO KNOW Opioid Legislation FAQs These FAQs represent a compilation of questions received from MSMS and MAFP members. Please note that this is
More informationMEDICAL MARIJUANA USE
AOM Chapter P-158 MEDICAL MARIJUANA USE GENERAL CONSIDERATIONS AND GUIDELINES: Massachusetts voters decided that this Commonwealth should join a growing number of other states that currently have laws
More informationChapter 11 How to state your conditions clearly to the doctor
Chapter 11 How to state your conditions clearly to the doctor Chapter 11 How to state your conditions clearly to the doctor While seeing doctor, details of your statement should include the following:
More informationSub. S.B. 119 As Passed by the Senate
AM3404 Sub. S.B. 119 As Passed by the Senate Topic: Opioid Data and Communication Expansion Act moved to amend as follows: In line 1 of the title, after "4723.52," insert "4729.01, 4729.44, 4729.75, 4729.79,
More informationOn December 27, 2017, the Lieutenant Governor signed into law several new requirements
OPIOID Alert MICHIGAN OSTEOPATHIC ASSOCIATION JANUARY 2018 On December 27, 2017, the Lieutenant Governor signed into law several new requirements aimed at combating the opioid epidemic. On the following
More informationTracker e-prescribing 101. The Complete Guide
Tracker e-prescribing 101. The Complete Guide Copyright Stratum Access Technologies, Inc. 2017 www.stratumaccess.com Electronic prescribing, known in short as e-prescribing, is a method of prescription
More informationARKANSAS DEPARTMENT OF HEALTH
ARKANSAS DEPARTMENT OF HEALTH RULES AND REGULATIONS PERTAINING TO CONTROLLED SUBSTANCES (July 26, 2001) I, Jerry Jones, P.D., Director of Pharmacy Services and Drug Control for the Arkansas Department
More informationAn Informational Outline of the Controlled Substances Act. Revised 2010¹
United States Department of Justice Drug Enforcement Administration Office of Diversion Control An Informational Outline of the Controlled Substances Act Revised 2010¹ ¹ This manual replaces all previous
More information9/3/2013. Presentation Objective. Prescription Drug Abuse Statistics Prescription Drug Abuse Statistics. Pharmaceutical Drugs and the Environment
Presentation Objective Background - Why do we need a regulation for the disposal of controlled substances. Disposal of Controlled Substances DEA Notice of Proposed Rulemaking AHMP 2013 National Conference
More informationOklahoma. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Oklahoma Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationThis license is required for any businesses offering tobacco products for sale.
Guidelines for City of Moorhead 500 Center Avenue, PO Box 779 Moorhead, MN 56560-0799 Phone: 218.299.5304 Fax: 218.299.5306 cityclerk@ci.moorhead.mn.us Moorhead City Code, 2-5A OVERVIEW This license is
More informationOCCUPATIONAL AND PROFESSIONAL LICENSING OPTOMETRIC PRACTITIONERS CONTINUING EDUCATION
TITLE 16 CHAPTER 16 PART 13 OCCUPATIONAL AND PROFESSIONAL LICENSING OPTOMETRIC PRACTITIONERS CONTINUING EDUCATION 16.16.13.1 ISSUING AGENCY: New Mexico Board of Optometry. [10-14-95; 2-15-99; 16.16.13.1
More informationISSUING AGENCY: Regulation and Licensing Department - NM Board of Osteopathic Medical Examiners.
Code of New Mexico Rules Title 16. Occupational and Professional Licensing Chapter 17. Osteopathic Medicine and Surgery Practitioners Part 5. Prescribing and Distribution of Controlled Substances 16.17.5.
More informationDRUG AND ALCOHOL POLICY
DRUG AND ALCOHOL POLICY I. Policy Section: 6.0 Human Resources II. Policy Subsection: 6.24 Drug and Alcohol Policy III. Policy Statement Grand Rapids Community College is committed to the elimination of
More informationNEW MEXICO DEPARTMENT OF HEALTH Administrative Manual ADMINISTRATION
Chapter NEW MEXICO DEPARTMENT OF HEALTH Administrative Manual ADMINISTRATION EFFECTIVE: Policy REVISED: 4/13/9 draft NALOXONE DISTRIBUTION POLICY I. PURPOSE: This New Mexico Department of Health (NMDOH)
More informationDEA: Combating the Supply
Drug Enforcement Administration DEA: Combating the Supply 2nd Annual Opioid Abuse and Heroin Overdose Solutions Summit Cathy Gallagher Diversion Program Manager Detroit Division May 11, 2017 1 Prescription
More informationDear DEA. Howard A. Heit, MD, FACP, FASAM,* Edward Covington, MD, and Patricia M. Good
PAIN MEDICINE Volume 5 Number 3 2004,* Edward Covington, MD, and Patricia M. Good *Georgetown University, Washington, District of Columbia; Cleveland Clinic Foundation, Cleveland, Ohio; Office of Diversion
More informationSECURTY REGULATIONS FOR MARIJUANA ESTABLISHMENTS. MGL. Ch. 94G, 12 - General Marijuana Establishment Operation
General Requirements: MGL. Ch. 94G, 12 - General Marijuana Establishment Operation (a) In addition to requirements established by regulation pursuant to section 4 of this chapter or by a city or town pursuant
More informationEMPLOYEE RELATIONS POLICY NO. 512
Beartooth Electric Cooperative, Inc. EMPLOYEE RELATIONS POLICY NO. 512 1. SUBJECT: ALCOHOL AND DRUG FREE WORKPLACE - DOT 2. PURPOSE: 2.1. Beartooth Electric Cooperative, Inc. (BEC) is committed to employee
More informationUtah. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Utah Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points of view
More informationillegal drugs including
Drug and Alcohol Abuse Prevention Information Fine Mortuary College (FMC) is committed to providingg a drug-freee environment for all college students and employees. Under the Drug-freee Workplacee Act
More informationH 7816 S T A T E O F R H O D E I S L A N D
LC00 01 -- H 1 S T A T E O F R H O D E I S L A N D IN GENERAL ASSEMBLY JANUARY SESSION, A.D. 01 A N A C T RELATING TO BUSINESSES AND PROFESSIONS - PHARMACIES Introduced By: Representatives Serpa, Canario,
More information19 TH JUDICIAL DUI COURT REFERRAL INFORMATION
19 TH JUDICIAL DUI COURT REFERRAL INFORMATION Please review the attached DUI Court contract and Release of Information. ******* You must sign and hand back to the court the Release of Information today.
More informationSmoke and Mirrors: Navigating Medical Marijuana in the Workplace
Smoke and Mirrors: Navigating Medical Marijuana in the Workplace Douglas P. Currier Elizabeth Connellan Smith dcurrier@verrilldana.com esmith@verrilldana.com (207) 253-4450 (207) 253-4460 Some Statistics
More information2016 Dr. Douglas H. Kay CPE Symposium
GREGORY CAMERON, R.Ph ASSISTANT PROFESSOR OF PHARMACY PRACTICE FIELD COORDINATOR COMMUNITY SITES HUSSON UNIVERSITY SCHOOL OF PHARMACY November 5, 2016 Please Silence All Electronic Equipment OBJECTIVES
More informationAppendix F Federation of State Medical Boards
Appendix F Federation of State Medical Boards Model Policy Guidelines for Opioid Addiction Treatment in the Medical Office SECTION I: PREAMBLE The (name of board) recognizes that the prevalence of addiction
More informationNYSHFA/NYSCAL 16 th Annual Nurse Leadership Conference. Timothy J. Dewey Sr. Investigator NYS Bureau of Narcotic Enforcement.
NYSHFA/NYSCAL 16 th Annual Nurse Leadership Conference Timothy J. Dewey Sr. Investigator NYS Bureau of Narcotic Enforcement May 2, 2018 1 May 2, 2018 2 Bureau Overview May 2, 2018 3 HISTORY 1850--Bureau
More informationPrescription Drug Take-Back Program Q s and A s
Got Drugs? Prescription Drug Take-Back Program Q s and A s What is the national drug take-back day? On Saturday, September 25 from 10:00 a.m. to 2:00 p.m., DEA and partner organizations will set up sites
More informationCoast Community College District BOARD POLICY Chapter 3 General Institution DRUG FREE ENVIRONMENT AND DRUG AND ALCOHOL ABUSE PREVENTION PROGRAM
Coast Community College District BOARD POLICY Chapter 3 General Institution AP 3550 DRUG FREE ENVIRONMENT AND DRUG AND ALCOHOL ABUSE PREVENTION PROGRAM References: Drug Free Schools and Communities Act,
More informationThe State of Cannabis in Oregon
The State of Cannabis in Oregon February 13, 2017 1 Status of legalization of cannabis in US Recreational Marijuana States (8 + D.C.): Colorado, Washington, Oregon, Alaska, D.C., California, Nevada, Massachusetts,
More informationWest Virginia. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile West Virginia Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationDrug-free Workplace Staff Rights and Responsibilities
Cherokee County School District, hereinafter school district, is committed to providing a safe work environment and to fostering the well-being and health of its employees. This commitment is jeopardized
More informationE. "Prospective employee": A person who has made application, whether written or oral, to CWI to become an employee.
POLICY FOR A DRUG AND ALCOHOL-FREE WORKPLACE I. STATEMENT OF PURPOSE Crossroads of Western Iowa recognizes the problems of substance abuse in society and in the workplace. Substance abuse poses a serious
More informationCardinal Health s Commitment to Opioid Anti-Diversion, Education and Misuse Prevention
Cardinal Health s Commitment to Opioid Anti-Diversion, Education and Misuse Prevention The people of Cardinal Health care deeply about the devastation opioid abuse has caused American families and communities
More informationCANNABIS MANAGEMENT CORPORATION REGULATIONS
c t CANNABIS MANAGEMENT CORPORATION REGULATIONS PLEASE NOTE This document, prepared by the Legislative Counsel Office, is an office consolidation of this regulation, current to August 11, 2018. It is intended
More informationConfirm Limit--Level of detectable drugs in urine to confirm a positive test.
Alcohol and Substance Abuse Policy Purpose To establish and maintain a safe, healthy working environment for all PVFD members; reduce the incidence of accidental injury to members and property; reduce
More informationDRUG-FREE AND ALCOHOL-FREE WORK PLACE
DRUG-FREE AND ALCOHOL-FREE WORK PLACE The following applies to all employees: 1. The Gloucester County Public School System has a vital interest in maintaining a safe, healthy, and productive environment
More informationControlled Substance Prescribing and Diversion. Pamela Polk, R. Ph., Inspector DHEC Bureau of Drug Control
Controlled Substance Prescribing and Diversion Pamela Polk, R. Ph., Inspector DHEC Bureau of Drug Control In 2010, approximately 38,329 unintentional drug overdose deaths occurred in the United States,
More informationUnderstanding the New Access to Cannabis for Medical Purposes Regulations
Understanding the New Access to Cannabis for Medical Purposes Regulations Health Canada August 2016 Table of Contents 1. Introduction 2. Health Canada's role 3. What it means for health care practitioners
More informationAct on Narcotic Drugs and Psychotropic Substances and Precursors thereof
Issuer: Riigikogu Type: act In force from: 13.05.2016 In force until: 22.11.2018 Translation published: 06.05.2016 Act on Narcotic Drugs and Psychotropic Substances and Precursors thereof Amended by the
More informationORDINANCE NO
ORDINANCE NO. 02011-06 AN ORDINANCE OF THE CITY COUNCIL OF THE CITY OF YUMA, ARIZONA, AMENDING CHAPTER 154 OF THE YUMA CITY CODE, AS AMENDED, RELATING TO ZONING REGULATIONS, PROVIDING FOR CHANGES TO THE
More informationThe Sale of Cannabis in Pharmacies. Michael H. Ghobrial, PharmD, JD Associate Director, Health Policy American Pharmacists Association
The Sale of Cannabis in Pharmacies Michael H. Ghobrial, PharmD, JD Associate Director, Health Policy American Pharmacists Association Development This activity was developed by the American Pharmacists
More informationPharmacy Law Disclosure Statement. Objectives 6/11/2016. I have no conflicts of interest to disclose related to this presentation.
Pharmacy Law 2016 Ronda H. Lacey, J.D., M.S. Pharm Disclosure Statement I have no conflicts of interest to disclose related to this presentation. Objectives At the conclusion of this continuing education
More informationCHAPTER Committee Substitute for Committee Substitute for Senate Bill No. 2760
CHAPTER 2008-64 Committee Substitute for Committee Substitute for Senate Bill No. 2760 An act relating to dentistry; amending s. 466.003, F.S.; providing a definition; amending s. 466.006, F.S.; revising
More informationCHAPTER 1 COMMUNITY PHARMACY M.ASHOKKUMAR DEPT OF PHARMACY PRACTICE SRM COLLEGE OF PHARMACY SRM UNIVERSITY
CHAPTER 1 COMMUNITY PHARMACY M.ASHOKKUMAR DEPT OF PHARMACY PRACTICE SRM COLLEGE OF PHARMACY SRM UNIVERSITY COMMUNITY PHARMACY OPERATIONS Technician Duties Related to Dispensing Over-the-Counter Drugs and
More informationReferred to Committee on Health and Human Services. SUMMARY Establishes an opioid overdose prevention policy for Nevada.
S.B. SENATE BILL NO. COMMITTEE ON HEALTH AND HUMAN SERVICES (ON BEHALF OF THE GOVERNOR) MARCH, 0 Referred to Committee on Health and Human Services SUMMARY Establishes an opioid overdose prevention policy
More informationTHE GENERAL ASSEMBLY OF PENNSYLVANIA HOUSE BILL
PRINTER'S NO. THE GENERAL ASSEMBLY OF PENNSYLVANIA HOUSE BILL No. 1 Session of 01 INTRODUCED BY DiGIROLAMO, GAINEY, ROZZI, DAVIS, O'BRIEN, WATSON, KINSEY, NEILSON, GODSHALL, MILLARD, HEFFLEY, MURT, TAYLOR,
More informationOffice of University Counsel and Secretary of the Board of Regents
To: From: University of Colorado Research Faculty President Bruce D. Benson University Counsel Patrick T. O Rourke Date: March 11, 2014 Re: Legality of Marijuana Research Colorado is one of twenty states
More informationMAINE OFFICE OF ATTORNEY GENERAL. A Legal Guide to Safely and Successfully Conducting a Collection Event for Unwanted Prescription Medications
MAINE OFFICE OF ATTORNEY GENERAL A Legal Guide to Safely and Successfully Conducting a Collection Event for Unwanted Prescription Medications Wear it out, make it do, or do without -- Old New England Saying
More informationAGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION. (Moscow, 23 December 2014)
AGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION (Moscow, 23 December 2014) Member States of the Eurasian Economic Union, hereinafter referred
More informationHEB Pharmacy Conference October 25, 2014
Texas State Board of Pharmacy Laws and Rules Update Allison Benz, R.Ph., M.S. Director of Professional Services Central Texas Society of Health-System Pharmacists Annual Seminar October 25, 2014 Texas
More informationGuidelines on the Sourcing of Medicinal Products for Sale or Supply by a Retail Pharmacy Business
Guidelines on the Sourcing of Medicinal Products for Sale or Supply by a Retail Pharmacy Business to Facilitate Compliance with Regulations 5(1)(g), 6, 8 and 11 of the Regulation of Retail Pharmacy Businesses
More informationPROPOSED REGULATION OF THE BOARD OF EXAMINERS FOR ALCOHOL, DRUG AND GAMBLING COUNSELORS LCB FILE NO. R069-17I
PROPOSED REGULATION OF THE BOARD OF EXAMINERS FOR ALCOHOL, DRUG AND GAMBLING COUNSELORS LCB FILE NO. R069-17I The following document is the initial draft regulation proposed by the agency submitted on
More informationRecall Guidelines. for Chinese Medicine Products
Recall Guidelines for Chinese Medicine Products April 2018 Recall Guidelines for Chinese Medicine Products Chinese Medicines Board Chinese Medicine Council of Hong Kong Compiled in September 2005 1 st
More informationl. The North Carolina Board of Pharmacy is a body duly organized under the laws
' l BEFORE THE NORTH CAROLNA BOARD OF PHARMACY n the Matter of: TMOTHY H. CLARK (License No. 12114 CONSENT ORDER THS MATTER came on to be considered at a prehearing conference (hereinafter, "Conference"
More informationC U S T O M E R D R I V E N. B U S I N E S S M I N D E D.
MAPS Update May 4, 2018 Presented by Kim Gaedeke, Acting Deputy Director Department of Licensing and Regulatory Affairs Andrew Hudson, Manager Drug Monitoring Section BPL-MAPS@Michigan.gov 517-373-1737
More informationNC General Statutes - Chapter 90 Article 5E 1
Article 5E. North Carolina Controlled Substances Reporting System Act. 90-113.70. Short title. This Article shall be known and may be cited as the "North Carolina Controlled Substances Reporting System
More informationTEXAS COMPASSIONATE-USE ACT
Ch. 301, 1 MEDICAL USE OF LOW-THC CANNABIS AND THE REGULATION OF RELATED ORGANIZATIONS AND INDIVIDUALS; REQUIRING A DISPENSING ORGANIZATION TO OBTAIN A LICENSE TO DISPENSE LOW-THC CANNABIS AND ANY EMPLOYEE
More information